Therapeutic Proteins

Abstract

Protein-based therapeutics are highly successful in clinic and currently enjoy unprecedented recognition of their potential. More than 100 genuine and similar number of modi fi ed therapeutic proteins are approved for clinical use in the European Union and the USA with 2010 sales of US$108 bln; monoclonal antibodies (mAbs) accounted for almost half (48%) of… (More)
DOI: 10.1007/978-1-61779-921-1

Topics

  • Blog articles referencing this paper

  • Presentations referencing similar topics